Clinical trial
The Prognostic Value of Urine NT-ProBNP in Neonatal Respiratory Distress
NCT02020993 is registered in ClinicalTrials.gov with Ankara University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Prognostic Value of Urine NT-ProBNP in Neonatal Respiratory Distress
- Lead sponsor
- Ankara University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 31, 2013
- Completion date
- January 31, 2015
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
neonatal respiratory distress